Data / Form D filings / Optikira, LLC
Optikira, LLC: Form D filings
Optikira, LLC, a pharmaceuticals company in Cleveland, OH, filed 6 Form D notices with the SEC between 2014 and 2019. The latest, on June 5, 2019, reports $2.7 million sold of a $5 million offering to 1 investor.
Find out what Optikira, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20600 CHAGRIN BLVD., SUITE 210, Cleveland, OH, 44122
- Phone
- (216) 455-3216
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1627178
The full lists. Form D filings in Ohio: 1,071 rows, $53.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2019 | Amendment | $5,000,000 | $2,700,000 | $2,300,000 | 1 | May 25, 2018 | sec.gov |
| Jul 31, 2018 | Amendment | $15,000,000 | $6,100,000 | $8,900,000 | 7 | Nov 30, 2014 | sec.gov |
| Jun 7, 2018 | New notice | $5,000,000 | $1,100,000 | $3,900,000 | 1 | May 25, 2018 | sec.gov |
| Aug 1, 2017 | Amendment | $15,000,000 | $5,300,000 | $9,700,000 | 7 | Nov 30, 2014 | sec.gov |
| Aug 2, 2016 | Amendment | $8,000,000 | $3,700,000 | $4,300,000 | 6 | Nov 30, 2014 | sec.gov |
| Dec 8, 2014 | New notice | $5,000,000 | $250,000 | $4,750,000 | 5 | Nov 30, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Chin | Director | |
| Bradley Backes | Director | |
| Baiju Shah | Director | |
| Theodore Torphy | Director |
Other pharmaceuticals companies in Ohio that filed recently
- EIKONOKLASTES THERAPEUTICS, INC. $16.1 million · Oct 6, 2026
Every Form D from the week of Jun 3, 2019 · All recent filings in Ohio · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Optikira, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.